Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...

Collaboration between TLI and AMDF underscores a shared commitment to making a meaningful difference in the lives of those affected by AMD. Together, TLI and AMDF are dedicated to advancing awareness, ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

Our eyesight is essential to getting around, but if you’re not careful it can be seriously challenged by age-related macular degeneration.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Smoking damages the blood vessels in the eyes, which over time increases the risk for several complications, including ...

The company offers year-round educational services on the conditions, using this month, in particular, to guide patients to ...

Protect your vision in 2025 with these 10 simple eye care habits, from screen breaks to a nutrient-rich diet, ensuring long-term eye health and clarity.